188 related articles for article (PubMed ID: 10823586)
21. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient.
Hazzalin CA; Cano E; Cuenda A; Barratt MJ; Cohen P; Mahadevan LC
Curr Biol; 1996 Aug; 6(8):1028-31. PubMed ID: 8805335
[TBL] [Abstract][Full Text] [Related]
22. p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
He Z; Cho YY; Liu G; Ma WY; Bode AM; Dong Z
J Biol Chem; 2003 Jul; 278(29):26435-42. PubMed ID: 12748197
[TBL] [Abstract][Full Text] [Related]
23. An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
Hu X; Janssen WE; Moscinski LC; Bryington M; Dangsupa A; Rezai-Zadeh N; Babbin BA; Zuckerman KS
Cancer Res; 2001 Aug; 61(16):6290-6. PubMed ID: 11507084
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
Crowe DL; Shemirani B
Anticancer Res; 2000; 20(5A):2945-9. PubMed ID: 11062705
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription.
See RH; Shi Y
Mol Cell Biol; 1998 Jul; 18(7):4012-22. PubMed ID: 9632786
[TBL] [Abstract][Full Text] [Related]
27. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.
Hocevar BA; Brown TL; Howe PH
EMBO J; 1999 Mar; 18(5):1345-56. PubMed ID: 10064600
[TBL] [Abstract][Full Text] [Related]
28. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
[TBL] [Abstract][Full Text] [Related]
29. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
30. Distinct roles of mitogen-activated protein kinase pathways in GATA-4 transcription factor-mediated regulation of B-type natriuretic peptide gene.
Kerkelä R; Pikkarainen S; Majalahti-Palviainen T; Tokola H; Ruskoaho H
J Biol Chem; 2002 Apr; 277(16):13752-60. PubMed ID: 11827958
[TBL] [Abstract][Full Text] [Related]
31. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
32. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
Boldt S; Weidle UH; Kolch W
Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
[TBL] [Abstract][Full Text] [Related]
33. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.
Han Z; Boyle DL; Chang L; Bennett B; Karin M; Yang L; Manning AM; Firestein GS
J Clin Invest; 2001 Jul; 108(1):73-81. PubMed ID: 11435459
[TBL] [Abstract][Full Text] [Related]
34. Calcium-stimulated mitogen-activated protein kinase activation elicits Bcl-xL downregulation and Bak upregulation in notexin-treated human neuroblastoma SK-N-SH cells.
Chen KC; Liu WH; Kao PH; Chang LS
J Cell Physiol; 2010 Jan; 222(1):177-86. PubMed ID: 19780038
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.
Hansen TV; Rehfeld JF; Nielsen FC
Mol Endocrinol; 1999 Mar; 13(3):466-75. PubMed ID: 10077003
[TBL] [Abstract][Full Text] [Related]
36. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
37. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
38. p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells.
Page K; Li J; Hershenson MB
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L955-64. PubMed ID: 11290520
[TBL] [Abstract][Full Text] [Related]
39. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase.
Wang XZ; Ron D
Science; 1996 May; 272(5266):1347-9. PubMed ID: 8650547
[TBL] [Abstract][Full Text] [Related]
40. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.
Lee RJ; Albanese C; Stenger RJ; Watanabe G; Inghirami G; Haines GK; Webster M; Muller WJ; Brugge JS; Davis RJ; Pestell RG
J Biol Chem; 1999 Mar; 274(11):7341-50. PubMed ID: 10066798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
